| Anthony Angelo Floreani, MD | |
|
300 Palmetto Health Pkwy Ste 401, Columbia, SC 29212 | |
| (803) 296-7332 | |
| (803) 296-7330 |
| Full Name | Anthony Angelo Floreani |
|---|---|
| Gender | Male |
| Speciality | Pulmonary Disease |
| Experience | 42 Years |
| Location | 300 Palmetto Health Pkwy Ste 401, Columbia, South Carolina |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1336197102 | NPI | - | NPPES |
| 1336197102 | Medicaid | NV | |
| 817995 | Medicaid | SC |
| Facility Name | Location | Facility Type |
|---|---|---|
| Waldo County General Hospital | Belfast, ME | Hospital |
| Penobscot Bay Medical Center | Rockport, ME | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Mainehealth | 7517860588 | 2067 |
News Archive
Synthego, the genome engineering company, has collaborated with The Krogan Lab, a world-renowned scientific research unit at the Quantitative Biosciences Institute (QBI) at the University of California, San Francisco (UCSF), to deliver multiple CRISPR-based engineered cell lines to accelerate the study of potential treatment targets for SARS-CoV-2, the novel coronavirus that causes COVID-19 disease.
Carriers of a BRCA2 variation specific to Iceland are more likely to develop aggressive and lethal prostate cancer than noncarriers, according to a study published online in the Journal of the National Cancer Institute.
Court cases regarding patent infringement effectively slow generics in coming to market, however US lawmakers and FDA continue to make it easier for generic drugs to gain approval (Cutting Edge Information).
A Coventry University scientist has developed a pioneering new way - using samples of beating heart tissue - to test the effect of drugs on the heart without using human or animal trials.
› Verified 6 days ago
| Entity Name | Mainehealth |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1790265502 PECOS PAC ID: 7517860588 Enrollment ID: O20040701000166 |
News Archive
Synthego, the genome engineering company, has collaborated with The Krogan Lab, a world-renowned scientific research unit at the Quantitative Biosciences Institute (QBI) at the University of California, San Francisco (UCSF), to deliver multiple CRISPR-based engineered cell lines to accelerate the study of potential treatment targets for SARS-CoV-2, the novel coronavirus that causes COVID-19 disease.
Carriers of a BRCA2 variation specific to Iceland are more likely to develop aggressive and lethal prostate cancer than noncarriers, according to a study published online in the Journal of the National Cancer Institute.
Court cases regarding patent infringement effectively slow generics in coming to market, however US lawmakers and FDA continue to make it easier for generic drugs to gain approval (Cutting Edge Information).
A Coventry University scientist has developed a pioneering new way - using samples of beating heart tissue - to test the effect of drugs on the heart without using human or animal trials.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Anthony Angelo Floreani, MD Po Box 743904, Atlanta, GA 30374-3904 Ph: (803) 296-7320 | Anthony Angelo Floreani, MD 300 Palmetto Health Pkwy Ste 401, Columbia, SC 29212 Ph: (803) 296-7332 |
News Archive
Synthego, the genome engineering company, has collaborated with The Krogan Lab, a world-renowned scientific research unit at the Quantitative Biosciences Institute (QBI) at the University of California, San Francisco (UCSF), to deliver multiple CRISPR-based engineered cell lines to accelerate the study of potential treatment targets for SARS-CoV-2, the novel coronavirus that causes COVID-19 disease.
Carriers of a BRCA2 variation specific to Iceland are more likely to develop aggressive and lethal prostate cancer than noncarriers, according to a study published online in the Journal of the National Cancer Institute.
Court cases regarding patent infringement effectively slow generics in coming to market, however US lawmakers and FDA continue to make it easier for generic drugs to gain approval (Cutting Edge Information).
A Coventry University scientist has developed a pioneering new way - using samples of beating heart tissue - to test the effect of drugs on the heart without using human or animal trials.
› Verified 6 days ago
William Cole Andrew, D.O. Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 14 Richland Medical Park Dr Ste 320, Columbia, SC 29203 Phone: 803-434-8721 | |
Seetharamprasad Madala, M.D. Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 1801 Sunset Dr, Columbia, SC 29203 Phone: 803-434-4153 Fax: 803-434-4160 | |
Michael Martin, Pulmonary Disease Medicare: Medicare Enrolled Practice Location: 2 Medical Park Rd, Columbia, SC 29203 Phone: 803-434-6956 | |
Dr. Terry A Grainger, MD Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 8 Richland Medical Park Dr Ste 100, Columbia, SC 29203 Phone: 803-434-3800 Fax: 803-744-2759 | |
Dr. Adelero Olayinka Adebajo, M.D. Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 1520 Laurel St, Columbia, SC 29201 Phone: 803-799-8407 Fax: 803-252-9070 | |
Jeff Z Brooker Jr., MD, RETIRED Pulmonary Disease Medicare: Medicare Enrolled Practice Location: 1625 Bernardin Ave, Columbia, SC 29204 Phone: 803-251-8985 | |
Dr. Ronald L Collins, MD Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 1711 Saint Julian Pl, Columbia, SC 29204 Phone: 803-779-0911 Fax: 803-256-2480 |